MIT Corporation life member and biotech pioneer Henri Termeer dies at 71
Termeer built Genzyme from a startup into a biotech powerhouse, while becoming an innovator in rare-disease drug development.
Termeer built Genzyme from a startup into a biotech powerhouse, while becoming an innovator in rare-disease drug development.
Differences in chromosome number may underlie variation among genetically identical individuals.
Beckman Foundation grant helps secure cryo-electron microscopy at MIT.nano facility.
Researchers program RNA nanoparticles that could protect against the virus.
Automated manufacturing could make it easier to develop and test new peptide drugs.
Bill and Melinda Gates Foundation awards MIT, University College London, and University of Kansas $17.6M for development and production of low-cost vaccines.
Takeda's $1 million gift to the MIT Koch Institute will advance research into how the immune system affects cancer.
Engineered bacteria produce rare and commercially useful compounds in large quantities.
Introducing such groups to potential drugs could make them more effective.
Professor Barbara Imperiali creates better biochemical tools for basic biology and drug development.
Cloud-based platform assists in managing, sharing data facilitates research.
Imaging technique that creates 3-D video of serotonin transport could aid antidepressant development.
From EpiPen pricing to government oversight, the making of medicine impacts all aspects of modern health care.
Freeze-dried cellular components can be rehydrated to churn out useful proteins.
Method that transports microbes through the stomach to the intestine may benefit human health.